Unified Huntington's disease rating scale: Reliability and consistency

被引:1728
作者
Kieburtz, K
Penney, JB
Como, P
Ranen, N
Shoulson, I
Feigin, A
Abwender, D
Greenamyre, JT
Higgins, D
Marshall, FJ
Goldstein, J
Steinberg, K
Shih, C
Richard, I
Hickey, C
Zimmerman, C
Orme, C
Claude, K
Oakes, D
Sax, DS
Kim, A
Hersch, S
Jones, R
Auchus, A
Olsen, D
BisseyBlack, C
Rubin, A
Schwartz, R
Dubinsky, R
Mallonee, W
Gray, C
Godfrey, N
Suter, G
Shannon, KM
Stebbins, GT
Jaglin, JA
Marder, K
Taylor, S
Louis, E
Moskowitz, C
Thorne, D
Zubin, N
Wexler, N
Swenson, MR
Paulsen, J
Swerdlow, N
Albin, R
Wernette, C
Walker, F
Hunt, V
机构
[1] Box 673, Department of Neurology, Univ. of Rochester Medical Center, Rochester, NY 14642
关键词
Huntington's disease; cognitive function; behavioral abnormalities; functional capacity; clinical research;
D O I
10.1002/mds.870110204
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Unified Huntington's Disease Rating Scale (UHDRS) was developed as a clinical rating scale to assess four domains of clinical performance and capacity in HD: motor function, cognitive function, behavioral abnormalities, and functional capacity. We assessed the internal consistency and the intercorrelations for the four domains and examined changes in ratings over time. We also performed an interrater reliability study of the motor assessment. We found there was a high degree of internal consistency within each of the domains of the UHDRS and that there were significant intercorrelations between total behavioral score, There was an excellent degree of interrater reliability for the motor scores. Our limited longitudinal database indicates that the UHDRS may be useful for tracking changes in the clinical features of HD over time. The UHDRS assesses relevant clinical features of HD and appears to be appropriate for repeated administration during clinical studies.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 12 条
[1]  
Benton A. L., 1978, MULTILINGUAL APHASIA
[2]   ASSESSMENT OF ADAPTIVE FUNCTIONING IN HUNTINGTONS-DISEASE [J].
BYLSMA, FW ;
ROTHLIND, J ;
HALL, MR ;
FOLSTEIN, SE ;
BRANDT, J .
MOVEMENT DISORDERS, 1993, 8 (02) :183-190
[3]  
FOLSTEIN SE, 1983, NEUROBEH TOXICOL TER, V5, P605
[4]   ASSESSMENT OF EXTRAPYRAMIDAL DISORDERS [J].
MARSDEN, CD ;
SCHACHTER, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (02) :129-151
[5]   FACTORS ASSOCIATED WITH SLOW PROGRESSION IN HUNTINGTONS-DISEASE [J].
MYERS, RH ;
SAX, DS ;
KOROSHETZ, WJ ;
MASTROMAURO, C ;
CUPPLES, LA ;
KIELY, DK ;
PETTENGILL, FK ;
BIRD, ED .
ARCHIVES OF NEUROLOGY, 1991, 48 (08) :800-804
[6]   DURATION OF ILLNESS IN HUNTINGTONS-DISEASE IS NOT RELATED TO AGE AT ONSET [J].
ROOS, RAC ;
HERMANS, J ;
VEGTERVANDERVLIS, M ;
VANOMMEN, GJB ;
BRUYN, GW .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (01) :98-100
[7]   HUNTINGTON DISEASE - CLINICAL CARE AND EVALUATION [J].
SHOULSON, I ;
FAHN, S .
NEUROLOGY, 1979, 29 (01) :1-3
[8]  
Shoulson I., 1989, QUANTIFICATION NEURO, P271
[9]  
Smith A, 1973, Symbol digit modalities test
[10]   Studies of interference in serial verbal reactions [J].
Stroop, JR .
JOURNAL OF EXPERIMENTAL PSYCHOLOGY, 1935, 18 :643-662